Cover Image

Prognostic role of androgen receptor expression in patients with metastatic triple negative breast cancer

Summary. At present, there are no valid prognostic biomarkers in patients with triple negative breast cancer (TNBC) except well known clinical factors such as tumor size, lymph node status, differentiation grade and proliferation rate. Aim: To evaluate the prognostic role of androgen receptor (AR) e...

Full description

Saved in:

Bibliographic Details
Date:	2023
Main Authors:	Lyalkin, S.A., Verevkina, N.O., Alekseyenko, O.O., Syvak, L.A.
Format:	Article
Language:	English
Published:	PH Akademperiodyka 2023
Subjects:	androgen receptor clinical prognosis overall survival triple negative breast cancer
Online Access:	https://exp-oncology.com.ua/index.php/Exp/article/view/2020-2-9
Tags:	Add Tag No Tags, Be the first to tag this record!
Journal Title:	Experimental Oncology

Institution

Experimental Oncology

Similar Items

Receptor status of tumor as prognostic factor in patients with bilateral breast cancer
by: Tsyhyka, D.Y., et al.
Published: (2013)

Prognostic factors in metastatic gastric carcinoma
by: Ben Kridis, W., et al.
Published: (2023)

Integral characteristic of the immune system state predicts breast cancer outcome
by: Stakheyeva, M., et al.
Published: (2023)

Tumor microenvironment-derived miRNAs as prognostic markers of breast cancer
by: Lukianova, N.Yu., et al.
Published: (2023)

Role of ABC-cassette transporters (MDR1, MRP1, BCRP) in the development of primary and acquired multiple drug resistance in patients with early and metastatic breast cancer
by: Kovalev, A.A., et al.
Published: (2013)

Deletions in metastatic colorectal cancer with chromothripsis
by: Skuja, E., et al.
Published: (2023)

A rare coincidence: facioscapulohumeral muscular dystrophy and breast cancer
by: Yazici, O., et al.
Published: (2013)

Epigenetics in breast cancer
by: Atalay, C.
Published: (2013)

Overview on locally advanced breast cancer: defining, epidemiology, and overview on neoadjuvant therapy
by: Yalcin, B.
Published: (2013)

Role of postmastectomy radiation therapy after neoadjuvant chemotherapy in locally advanced breast cancer
by: Akyurek, S., et al.
Published: (2013)

Management of non-inflammatory locally advanced breast cancer: focus on surgical approaches
by: Eroğlu, A., et al.
Published: (2013)

Disseminated tumor cells and enhanced level of some cytokines in bone marrow and peripheral blood of breast cancer patients as predictive factors of tumor progression
by: Semesiuk, N., et al.
Published: (2013)

Male breast cancer: clinical presentation, diagnosis, treatment
by: Hotko, Y.S.
Published: (2013)

Breast reconstruction
by: Kaya, B., et al.
Published: (2013)

Staging, risk assessment and screening of breast cancer
by: Yalcin, B.
Published: (2013)

Postmastectomy radiation therapy in locally advanced breast cancer
by: Yavas, G., et al.
Published: (2013)

Positron emission tomography/computed tomography in locally advanced breast cancer
by: Ozkan, E.
Published: (2013)

Cytochrome P450 content in primary tumors and liver metastases of patients with metastatic colorectal cancer
by: Burlaka, A.P., et al.
Published: (2023)

High expression of GLI1 is associated with better survival in advanced SCLC
by: Kozirovskis, V., et al.
Published: (2023)

Assessment of prognostic and diagnostic value of some biomarkers in hepatocellular carcinoma
by: Çavuş, B., et al.
Published: (2023)

Antiproliferative and apoptotic effects of anti-human HB-EGF neutralizing polyclonal antibodies in vitro
by: Siromolot, A.A., et al.
Published: (2023)

Association of circulating miR-21, -205, and -182 with response of luminal breast cancers to neoadjuvant FAC and AC treatment
by: Chekhun, V.F., et al.
Published: (2023)

Detection of breast cancer presenting as a mass in women with dense breasts — digital breast tomosynthesis versus full-field digital mammography
by: Babkina, T.M., et al.
Published: (2023)

Incidence and long-term effects of treatment of malignant germ cell neoplasms in Ukraine
by: Fedorenko, Z.P., et al.
Published: (2023)

Clinical and pathological prognostic factors in patients with stage III–IVA-B oral squamous cell carcinoma
by: Kravets, O.V., et al.
Published: (2023)

FoxP3 gene polymorphism is associated with breast cancer in Iranian patients
by: Arabpour, F., et al.
Published: (2018)

Tumor microenvironment and metabolic factors: contribution to gastric cancer
by: Bubnovskaya, L., et al.
Published: (2023)

Amplification and co-regulators of androgen receptor gene in prostate cancer
by: Golias, Ch., et al.
Published: (2009)

NANOG as prognostic factor of prostate cancer course
by: Zadvornyi, T.V., et al.
Published: (2023)

Androgen deprivation therapy in combination with chemotherapy in patients with castrate-naive metastatic prostate cancer
by: A. N. Dubinina
Published: (2016)

Association of allele variants of receptor gene of androgens (by the number of CAG-repeats) with androgen dependent hormonal metabolic indices of the organism
by: V. V. Korpachev, et al.
Published: (2015)

FUT3 expression in human breast cancer cells under hypoxia and serum deprivation
by: Albuquerque, A.P.B., et al.
Published: (2023)

Burden of malignant melanoma in Ukraine in 2002–2013: incidence, mortality and survival
by: Korovin, S., et al.
Published: (2023)

The Kі-67 marker for assessing the effectiveness of systemic or regional neoadjuvant polychemotherapy in patients with locally advanced breast cancer
by: Dumanskiy, Y.V., et al.
Published: (2023)

The impact of maximal strength training on quality of life among women with breast cancer undergoing treatment
by: Cešeiko, R., et al.
Published: (2023)

Prognostic significance of microRNA-200b and ERCC1 expression in tumor cells of patients with esophageal cancer
by: Kirkilevsky, S.I., et al.
Published: (2023)

A network model for structural survivability
by: Додонов, О. Г., et al.
Published: (2021)

Prognosis models of nitrates and orthophosphates content in surface waters
by: Mitryasova, Olena P., et al.
Published: (2022)

Sensitivity of chronic lymphocytic leukemia cells to chemotherapeutic drugs ex vivo depends on expression status of cell surface receptors
by: Shcherbina, V., et al.
Published: (2023)

Bladder sparing surgery in high-grade bladder cancer
by: Yakovlev, P.G., et al.
Published: (2023)